Periodontal disease: Linking the primary inflammation to bone loss

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Di Benedetto, Adriana ^a   Gigante, Isabella ^a   Colucci, Silvia ^a   Grano, Maria ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 17; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; CYTOKINE; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; B LYMPHOCYTE ACTIVATION; BONE REMODELING; CELL POPULATION; CELL SURVIVAL; CYTOKINE RELEASE; HUMAN; INFLAMMATION; INFLAMMATORY CELL; INNATE IMMUNITY; LYMPHOCYTE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PERIODONTAL DISEASE; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TH2 CELL; ALVEOLAR BONE LOSS; B LYMPHOCYTE; BACTERIAL INFECTION; GENE EXPRESSION; GENETICS; HELPER CELL; IMMUNOLOGY; MICROBIOLOGY; PATHOLOGY; PERIODONTITIS;

ADAPTIVE IMMUNITY; ALVEOLAR BONE LOSS; B-LYMPHOCYTES; BACTERIAL INFECTIONS; CYTOKINES; GENE EXPRESSION; HUMANS; IMMUNITY, INNATE; INFLAMMATION; PERIODONTITIS; PHAGOCYTES; T-LYMPHOCYTES, HELPER-INDUCER; TOLL-LIKE RECEPTORS;

EID: 84878650846     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/503754     Document Type: Review

References (73)

1. Graves D. T., Cochran D., The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. Journal of Periodontology 2003 74 3 391 401 2-s2.0-0038505147 10.1902/jop.2003.74.3.391 (Pubitemid 36939356)
2. Garlet G. P., Cardoso C. R., Silva T. A., Ferreira B. R., Ávila-Campos M. J., Cunha F. Q., Silva J. S., Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Oral Microbiology and Immunology 2006 21 1 12 20 2-s2.0-33645077356 10.1111/j.1399-302X.2005.00245.x
3. Hansson G. K., Edfeldt K., Toll to be paid at the gateway to the vessel wall. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 6 1085 1087 2-s2.0-20144362803 10.1161/01.ATV.0000168894.43759.47 (Pubitemid 40776589)
4. Hayashi F., Means T. K., Luster A. D., Toll-like receptors stimulate human neutrophil function. Blood 2003 102 7 2660 2669 2-s2.0-0141705297 10.1182/blood-2003-04-1078 (Pubitemid 37193610)
5. Benakanakere M., Kinane D. F., Innate cellular responses to the periodontal biofilm. Frontiers of Oral Biology 2012 1 41 55
6. Bostanci N., Belibasakis G. N., Porphyromonas gingivalis: an invasive and evasive opportunistic oral pathogen. FEMS Microbiology Letters 2012 333 1 1 9 10.1111/j.1574-6968.2012.02579.x
7. Mahanonda R., Pichyangkul S., Toll-like receptors and their role in periodontal health and disease. Periodontology 2000 2007 43 1 41 55 2-s2.0-33846064340 10.1111/j.1600-0757.2006.00179.x
8. Hayashi C., Gudino C. V., Gibson F. C. III, Genco C. A., Pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways. Molecular Oral Microbiology 2010 25 5 305 316 2-s2.0-77956375710 10.1111/j.2041-1014.2010. 00582.x
9. Hans M., Hans V. M., Toll-like receptors and their dual role in periodontitis: a review. Journal of Oral Science 2011 53 3 263 271 10.2334/josnusd.53.263
10. Garlet G. P., Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defense and tissue destruction viewpoints. Journal of Dental Research 2010 89 12 1349 1363 2-s2.0-78650083063 10.1177/0022034510376402
11. Cochran D. L., Inflammation and bone loss in periodontal disease. Journal of Periodontology 2008 79 8 1569 1576 2-s2.0-49449113092 10.1902/jop.2008. 080233
12. Payne J. B., Golub L. M., Using tetracyclines to treat osteoporotic/osteopenic bone loss: from the basic science laboratory to the clinic. Pharmacological Research 2011 63 2 121 129 2-s2.0-79251609692 10.1016/j.phrs.2010.10.006
13. Han Y. W., Shi W., Huang G. T. J., Kinder Haake S., Park N. H., Kuramitsu H., Genco R. J., Interactions between periodontal bacteria and human oral epithelial cells: fusobacterium nucleatum adheres to and invades epithelial cells. Infection and Immunity 2000 68 6 3140 3146 2-s2.0-0034079238 10.1128/IAI.68.6.3140-3146.2000 (Pubitemid 30340401)
14. Trevani A. S., Chorny A., Salamone G., Vermeulen M., Gamberale R., Schettini J., Raiden S., Geffner J., Bacterial DNA activates human neutrophils by a CpG-independent pathway. European Journal of Immunology 2003 33 11 3164 3174 2-s2.0-0242559046 10.1002/eji.200324334 (Pubitemid 37428349)
15. Nanbara H., Wara-Aswapati N., Nagasawa T., Modulation of Wnt5a expression by periodontopathic bacteria. PLoS ONE 2012 7 4 e34434 10.1371/journal.pone. 0034434
16. Tew J. G., El Shikh M. E., El Sayed R. M., Schenkein H. A., Dendritic cells, antibodies reactive with oxLDL, and inflammation. Journal of Dental Research 2012 91 1 8 16 10.1177/0022034511407338
17. Ekhlassi S., Scruggs L. Y., Garza T., Montufar-Solis D., Moretti A. J., Klein J. R., Porphyromonas gingivalis lipopolysaccharide induces tumor necrosis factor- α and interleukin-6 secretion, and CCL25 gene expression, in mouse primary gingival cell lines: interleukin-6-driven activation of CCL2. Journal of Periodontal Research 2008 43 4 431 439 2-s2.0-45549096261 10.1111/j.1600-0765.2008.01090.x
18. Ara T., Kurata K., Hirai K., Uchihashi T., Uematsu T., Imamura Y., Furusawa K., Kurihara S., Wang P. L., Human gingival fibroblasts are critical in sustaining inflammation in periodontal disease. Journal of Periodontal Research 2009 44 1 21 27 2-s2.0-58149343553 10.1111/j.1600-0765.2007.01041.x
19. Morandini A. C. F., Sipert C. R., Gasparoto T. H., Greghi S. L. A., Passanezi E., Rezende M. L. R., Sant'ana A. P., Campanelli A. P., Garlet G. P., Santos C. F., Differential production of macrophage inflammatory protein-1 α stromal-derived factor-1, and IL-6 by human cultured periodontal ligament and gingival fibroblasts challenged with lipopolysaccharide from P. gingivalis. Journal of Periodontology 2010 81 2 310 317 2-s2.0-77649230692 10.1902/jop.2009.090375
20. Chang Y. C., Yang S. F., Lai C. C., Liu J. Y., Hsieh Y. S., Regulation of matrix metalloproteinase production by cytokines, pharmacological agents and periodontal pathogens in human periodontal ligament fibroblast cultures. Journal of Periodontal Research 2002 37 3 196 203 2-s2.0-0036597975
21. Ohshima M., Yamaguchi Y., Otsuka K., Sato M., Ishikawa M., Laminin expression by human periodontal ligament fibroblasts. Connective Tissue Research 2006 47 3 149 156 2-s2.0-33745008198 10.1080/03008200600685475 (Pubitemid 43860236)
22. Scheres N., Laine M. L., de Vries T. J., Everts V., van Winkelhoff A. J., Gingival and periodontal ligament fibroblasts differ in their inflammatory response to viable Porphyromonas gingivalis. Journal of Periodontal Research 2010 45 2 262 270 2-s2.0-77950264849 10.1111/j.1600-0765.2009.01229.x
23. Jung I. H., Lee D. E., Yun J. H., Anti-inflammatory effect of (-)-epigallocatechin-3-gallate on Porphyromonas gingivalis lipopolysaccharide- stimulated fibroblasts and stem cells derived from human periodontal ligament. Journal of Periodontal & Implant Science 2012 42 6 185 195 10.5051/jpis.2012.42.6.185
24. Zhang W., Swearingen E. B., Ju J., Rigney T., Tribble G. D., Porphyromonas gingivalis invades osteoblasts and inhibits bone formation. Microbes and Infection 2010 12 11 838 845 2-s2.0-77957752387 10.1016/j.micinf.2010.05.011
25. Zhang W., Ju J., Rigney T., Tribble G., Integrin alpha5beta1-fimbriae binding and actin rearrangement are essential for Porphyromonas gingivalis invasion of osteoblasts and subsequent activation of the JNK pathway. BMC Microbiology 2013 13 1, article 5
26. 2-mediated RANKL/osteoprotegerin regulation. Journal of Periodontal Research 2010 45 6 772 779 2-s2.0-77958527926 10.1111/j.1600-0765.2010.01298.x
27. Tang Y., Sun F., Li X., Zhou Y., Yin S., Zhou X., Porphyromonas endodontalis lipopolysaccharides induce RANKL by mouse osteoblast in a way different from that of Escherichia coli lipopolysaccharide. Journal of Endodontics 2011 37 12 1653 1658 10.1016/j.joen.2011.08.015
28. Cutler C. W., Jotwani R., Antigen-presentation and the role of dendritic cells in periodontitis. Periodontology 2000 2004 35 135 157 2-s2.0-2942628114 10.1111/j.0906-6713.2004.003560.x (Pubitemid 41742821)
29. Murphy K. M., Reiner S. L., The lineage decisions of helper T cells. Nature Reviews Immunology 2002 2 12 933 944 2-s2.0-0036885067 10.1038/nri954 (Pubitemid 37323214)
30. Appay V., van Lier R. A. W., Sallusto F., Roederer M., Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 2008 73 11 975 983 2-s2.0-55949116720 10.1002/cyto.a.20643
31. Reg cell lineages: a (co-)evolutionary perspective. Nature Reviews Immunology 2009 9 12 883 889 2-s2.0-72949106340 10.1038/nri2660
32. Berthelot J. M., Le Goff B., Rheumatoid arthritis and periodontal disease. Joint Bone Spine 2010 77 6 537 541 2-s2.0-78649907653 10.1016/j.jbspin.2010.04.015
33. Ohlrich E. J., Cullinan M. P., Seymour G. J., The immunopathogenesis of periodontal disease. Australian Dental Journal 2009 54 supplement 1 S2 S10 2-s2.0-77649200021
34. Matsumoto C., Oda T., Yokoyama S., Toll-like receptor 2 heterodimers, TLR2/6 and TLR2/1 induce prostaglandin E production by osteoblasts, osteoclast formation and inflammatory periodontitis. Biochemical and Biophysical Research Communications 2012 428 1 110 115 10.1016/j.bbrc.2012.10.016
35. Lerner U. H., Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis. Journal of Dental Research 2006 85 7 596 607 2-s2.0-33746136543 (Pubitemid 44085948)
36. Park Y. D., Kim Y. S., Jung Y. M., Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells. Cytokine 2012 60 1 284 293 10.1016/j.cyto.2012.05.021
37. Liu D., Xu J. K., Figliomeni L., Huang L., Pavlos N. J., Rogers M., Tan A., Price P., Zheng M. H., Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. International Journal of Molecular Medicine 2003 11 1 17 21 2-s2.0-0345147090
38. Lu H. K., Chen Y. L., Chang H. C., Li C. L., Kuo M. Y. P., Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis. Journal of Periodontal Research 2006 41 4 354 360 2-s2.0-33748549017 10.1111/j.1600-0765.2006.00883.x (Pubitemid 44392308)
39. Brunetti G., Colucci S., Pignataro P., Coricciati M., Mori G., Cirulli N., Zallone A., Grassi F. R., Grano M., T cells support osteoclastogenesis in an in vitro model derived from human periodontitis patients. Journal of Periodontology 2005 76 10 1675 1680 2-s2.0-27844548531 10.1902/jop.2005.76.10. 1675 (Pubitemid 41645576)
40. Belibasakis G. N., Bostanci N., The RANKL-OPG system in clinical periodontology. Journal of Clinical Periodontology 2012 39 3 239 248 10.1111/j.1600-051X.2011.01810.x
41. Han X., Lin X., Seliger A. R., Eastcott J., Kawai T., Taubman M. A., Expression of receptor activator of nuclear factor- B ligand by B cells in response to oral bacteria. Oral Microbiology and Immunology 2009 24 3 190 196 2-s2.0-67449137943 10.1111/j.1399-302X.2008.00494.x
42. Kawai T., Matsuyama T., Hosokawa Y., Makihira S., Seki M., Karimbux N. Y., Goncalves R. B., Valverde P., Dibart S., Li Y. P., Miranda L. A., Ernst C. W. O., Izumi Y., Taubman M. A., B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. American Journal of Pathology 2006 169 3 987 998 2-s2.0-33748788554 10.2353/ajpath.2006.060180 (Pubitemid 44411961)
43. Yamaguchi M., Ukai T., Kaneko T., Yoshinaga M., Yokoyama M., Ozaki Y., Hara Y., T cells are able to promote lipopolysaccharide-induced bone resorption in mice in the absence of B cells. Journal of Periodontal Research 2008 43 5 549 555 2-s2.0-50849093586 10.1111/j.1600-0765.2008.01083.x
44. Crotti T., Smith M. D., Hirsch R., Soukoulis S., Weedon H., Capone M., Ahern M. J., Haynes D., Receptor activator NF B ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. Journal of Periodontal Research 2003 38 4 380 387 2-s2.0-0141448875 (Pubitemid 37465544)
45. Yarilina A., Xu K., Chen J., Ivashkiv L. B., TNF activates calcium-nuclear factor of activated T cells (NFAT)c1 signaling pathways in human macrophages. Proceedings of the National Academy of Sciences of the United States of America 2011 108 4 1573 1578 2-s2.0-79952159585 10.1073/pnas. 1010030108
46. Graves D., Cytokines that promote periodontal tissue destruction. Journal of Periodontology 2008 79 8 1585 1591 2-s2.0-49449085034 10.1902/jop.2008. 080183
47. Ritchlin C. T., Haas-Smith S. A., Li P., Hicks D. G., Schwarz E. M., Mechanisms of TNF- α-and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. The Journal of Clinical Investigation 2003 111 6 821 831 2-s2.0-0037364369 10.1172/JCI200316069 (Pubitemid 37074957)
48. Garlet G. P., Martins W. Jr., Fonseca B. A. L., Ferreira B. R., Silva J. S., Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. Journal of Clinical Periodontology 2004 31 8 671 679 2-s2.0-4143063439 10.1111/j.1600-051X.2004.00545.x (Pubitemid 39092231)
49. Tjoa S. T. S., de Vries T. J., Schoenmaker T., Kelder A., Loos B. G., Everts V., Formation of osteoclast-like cells from peripheral blood of periodontitis patients occurs without supplementation of macrophage colony-stimulating factor. Journal of Clinical Periodontology 2008 35 7 568 575 2-s2.0-44849115477 10.1111/j.1600-051X.2008.01241.x
50. Hernández M., Dutzan N., García-Sesnich J., Host-Pathogen Interactions in Progressive Chronic Periodontitis, Journal of Dental Research 2011 90 10 1164 1170
51. Huang H., Zhao N., Xu X., Dose-specific effects of tumor necrosis factor alpha on osteogenic differentiation of mesenchymal stem cells. Cell Proliferation 2011 44 5 420 427 10.1111/j.1365-2184.2011.00769.x
52. Vernal R., Dutzan N., Chaparro A., Puente J., Valenzuela M. A., Gamonal J., Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. Journal of Clinical Periodontology 2005 32 4 383 389 2-s2.0-17644371321 10.1111/j.1600-051X.2005.00684.x (Pubitemid 40569601)
53. Cardoso C. R., Garlet G. P., Crippa G. E., Rosa A. L., Júnior W. M., Rossi M. A., Silva J. S., Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. Oral Microbiology and Immunology 2009 24 1 1 6 2-s2.0-57649215597 10.1111/j.1399-302X.2008.00463.x
54. Kelly M. N., Kolls J. K., Happel K., Schwartzman J. D., Schwarzenberger P., Combe C., Moretto M., Khan I. A., Interteukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infection and Immunity 2005 73 1 617 621 2-s2.0-11144286392 10.1128/IAI.73.1.617-621.2005 (Pubitemid 40041158)
55. Yu J. J., Ruddy M. J., Wong G. C., Sfintescu C., Baker P. J., Smith J. B., Evans R. T., Gaffen S. L., An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 2007 109 9 3794 3802 2-s2.0-34147126728 10.1182/blood-2005-09-010116 (Pubitemid 46641730)
56. Boyle W. J., Simonet W. S., Lacey D. L., Osteoclast differentiation and activation. Nature 2003 423 6937 337 342 2-s2.0-0037673945 10.1038/nature01658 (Pubitemid 40852708)
57. Weaver C. T., Harrington L. E., Mangan P. R., Gavrieli M., Murphy K. M., Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006 24 6 677 688 2-s2.0-33744984785 10.1016/j.immuni.2006.06.002 (Pubitemid 43867371)
58. Marsters S. A., Pitti R. A., Sheridan J. P., Ashkenazi A., Control of apoptosis signaling by Apo2 ligand. Recent Progress in Hormone Research 1999 54 225 234 2-s2.0-0033382845 (Pubitemid 30074693)
59. Zauli G., Secchiero P., The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology. Cytokine and Growth Factor Reviews 2006 17 4 245 257 2-s2.0-33745854287 10.1016/j.cytogfr.2006.04.002 (Pubitemid 44038614)
60. Roux S., Lambert-Comeau P., Saint-Pierre C., Lépine M., Sawan B., Parent J. L., Death receptors, Fas and TRAIL receptors, are involved in human osteoclast apoptosis. Biochemical and Biophysical Research Communications 2005 333 1 42 50 2-s2.0-20444458264 10.1016/j.bbrc.2005.05.092 (Pubitemid 40813444)
61. Colucci S., Brunetti G., Cantatore F. P., Oranger A., Mori G., Pignataro P., Tamma R., Grassi F. R., Zallone A., Grano M., The death receptor DR5 is involved in TRAIL-mediated human osteoclast apoptosis. Apoptosis 2007 12 9 1623 1632 2-s2.0-34547104357 10.1007/s10495-007-0095-3 (Pubitemid 47106894)
62. Brunetti G., Oranger A., Mori G., Trail is involved in human osteoclast apoptosis. Annals of the New York Academy of Sciences 2007 1116 316 322 10.1196/annals.1402.011 (Pubitemid 350274317)
63. Secchiero P., Gonelli A., Mirandola P., Melloni E., Zamai L., Celeghini C., Milani D., Zauli G., Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway. Blood 2002 100 7 2421 2429 2-s2.0-0036786215 10.1182/blood-2002-01-0047
64. Secchiero P., Melloni E., Heikinheimo M., Mannisto S., Di Pietro R., Iacone A., Zauli G., TRAIL regulates normal erythroid maturation through an ERK-dependent pathway. Blood 2004 103 2 517 522 2-s2.0-0942298610 10.1182/blood-2003-06-2137 (Pubitemid 38140081)
65. Zauli G., Rimondi E., Nicolin V., Melloni E., Celeghini C., Secchiero P., TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF. Blood 2004 104 7 2044 2050 2-s2.0-4644323767 10.1182/blood-2004-03-1196 (Pubitemid 39297855)
66. Mori G., Brunetti G., Colucci S., Ciccolella F., Coricciati M., Pignataro P., Oranger A., Ballini A., Farronato D., Mastrangelo F., Tetè S., Grassi F. R., Grano M., Alteration of activity and survival of osteoblasts obtained from human periodontitis patients: role of TRAIL. Journal of Biological Regulators and Homeostatic Agents 2007 21 3-4 105 114 2-s2.0-42149149379 (Pubitemid 351524044)
67. Alexander E. H., Rivera F. A., Marriott I., Anguita J., Bost K. L., Hudson M. C., Staphylococcus aureus-induced tumor necrosis factor-related apoptosis-inducing ligand expression mediates apoptosis and caspase-8 activation in infected osteoblasts. BMC Microbiology 2003 3, article 5 10.1186/1471-2180-3-5
68. Brunetti G., Oranger A., Mori G., TRAIL effect on osteoclast formation in physiological and pathological conditions. Frontiers in Bioscience 2011 1 3 1154 1161
69. Vitovski S., Phillips J. S., Sayers J., Croucher P. I., Investigating the interaction between osteoprotegerin and receptor activator of NF- B or tumor necrosis factor-related apoptosis-inducing ligand: evidence for a pivotal role for osteoprotegerin in regulating two distinct pathways. The Journal of Biological Chemistry 2007 282 43 31601 31609 2-s2.0-35748946639 10.1074/jbc.M706078200 (Pubitemid 350044899)
70. Mori G., Brunetti G., Collucci S., Oranger A., Ciccolella F., Sardone F., Pignataro P., Mori C., Karapanou V., Ballini A., Mastrangelo F., Tetè S., Grassi F. R., Grano M., Osteoblast apoptosis in periodontal disease: role of TNF-related apoptosis-inducing ligand. International Journal of Immunopathology and Pharmacology 2009 22 1 95 103 2-s2.0-62649131718
71. Brunetti G., Oranger A., Carbone C., Osteoblasts display different responsiveness to TRAIL-induced apoptosis during their differentiation process. Cell Biochemistry and Biophysics 10.1007/s12013-013-9616-6
72. Lucas H., Bartold P. M., Dharmapatni A. A., Holding C. A., Haynes D. R., Inhibition of apoptosis in periodontitis. Journal of Dental Research 2010 89 1 29 33 2-s2.0-72449170214 10.1177/0022034509350708
73. Bartold P. M., Cantley M. D., Haynes D. R., Mechanisms and control of pathologic bone loss in periodontitis. Periodontology 2000 2010 53 1 55 69 2-s2.0-77953192729 10.1111/j.1600-0757.2010.00347.x